Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Vivodyne Inc.

Headquarters: Philadelphia, PA, United States of America
Year Founded: 2020
Status: Private

BioCentury | Oct 18, 2024
Discovery & Translation

Making preclinical models more human-like

Ten new mouse and 3D cell models meant to better mimic human organ function or disease
BioCentury | Oct 11, 2024
Product Development

Discovery through perturbation: taking causality into your own hands 

A company’s experimental setup and scale shape the type of AI it uses and questions it can ask
BioCentury | Oct 1, 2024
Management Tracks

Prothena names Swanson CDO

Plus: Chris Williams at the helm of Culture, GentiBio scoops up former Structure CMO and updates on Burning Rock, National Resilience and Grünenthal
BioCentury | Sep 27, 2024
Discovery & Translation

Three tensions in early-stage translation: BioCentury Grand Rounds

Across disciplines, researchers are navigating trade-offs in advancing translation that boil down to scope versus focus 
BioCentury | May 9, 2024
Management Tracks

Reginald Seeto at the helm of Scipher

Plus: New heads of commercial and strategy at AdvanCell, and an update from Vivodyne
BioCentury | Feb 1, 2024
Management Tracks

Rhodes, Manhard join Acadia

Plus: Vivodyne hires Menschik as CTO and an update from Enhanc3D
BioCentury | Nov 22, 2023
Deals

Nov. 22 Quick Takes: Boehringer buying bacterial oncology play T3 

Plus: Syncona reaches deal to take Freeline private, and updates from InDex, Evelo and more
Items per page:
1 - 7 of 7